(Q42789311)

7 November 2017

title

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease (English)

1 reference

Lúcia Maria da Cunha Galvão

7 November 2017

0 references

0 references

1 reference

Bianca Zingales

8

0 references

1 reference

ORCID Public Data File 2021

author name string

Margoth Moreno

1

1 reference

7 November 2017

Daniella A D'ávila

2

1 reference

7 November 2017

Marcelo N Silva

3

1 reference

7 November 2017

Lúcia Mc Galvão

4

1 reference

7 November 2017

Andrea M Macedo

5

1 reference

7 November 2017

Egler Chiari

6

1 reference

7 November 2017

Eliane D Gontijo

7

1 reference

7 November 2017

language of work or name

1 reference

1 November 2010

1 reference

Memórias do Instituto Oswaldo Cruz

7 November 2017

published in

1 reference

7 November 2017

volume

105

1 reference

7 November 2017

issue

7

1 reference

7 November 2017

page(s)

918-924

1 reference

Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Hemocultures for the parasitological diagnosis of human chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

A critical review on Chagas disease chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Probing the genetic population structure of Trypanosoma cruzi with polymorphic microsatellites

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

The future of Chagas disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Ergosterol biosynthesis and drug development for Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762010000700014

10.1590/S0074-02762010000700014

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference